Announced Tue, 19 May · 18:24 IST

Re- Appointment of M/s. Vas & Co., Chartered Accountants as Internal Auditors of the Company for Financial Year 2026-27

Going ConcernEmphasis Of MatterPat NegativeNegative Operating CashflowContingent Liabilities IncreasedDebt Equity ThresholdResults View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-9.4%1-day move
₹14.08
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-9.4-13.8-18.1-22.2-29.6-44.2-44.5-52.1
Up moveDown movePending
AI summary

Gayatri BioOrganics Limited reported a net loss of Rs 111.18 lakhs for FY 2025-26, worsening from Rs 72.65 lakhs loss in the prior year—a 53% increase in losses. The company has zero revenue from operations and relies on other income. The balance sheet shows negative equity of Rs 3,700.49 lakhs, indicating technical insolvency. Total assets stood at Rs 171.75 lakhs against borrowings of Rs 3,523.14 lakhs. The company has operating cash outflows of Rs 73.54 lakhs and contingent liabilities totaling approximately Rs 2,486 lakhs across multiple disputed tax matters. Statutory auditors MGR & Co. issued an unmodified opinion with an Emphasis of Matter on undisclosed notes. The board also appointed M/s. Vas & Co. as internal auditors for FY 2026-27. The financial statements are prepared on a going concern basis relying on promoter comfort letters.

Likely market impact

The company's financial health is critically weak with negative equity, mounting losses, and no operational revenue. Shareholders face extreme risk as the company is technically insolvent with reliance on promoter support. The stock carries high speculative risk.